CureVac
CVAC
CVAC was delisted on the 5th of January, 2026.
88 hedge funds and large institutions have $373M invested in CureVac in 2023 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 24 reducing their positions, and 12 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
79% more call options, than puts
Call options by funds: $2.94M | Put options by funds: $1.64M
58% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 12
46% more capital invested
Capital invested by funds: $256M → $373M (+$117M)
38% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 24
7% more funds holding
Funds holding: 82 → 88 (+6)
0.56% less ownership
Funds ownership: 16.53% → 15.97% (-0.56%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$6.71M |
| 2 |
EP
Eversept Partners
New York
|
+$3.2M |
| 3 |
Morgan Stanley
New York
|
+$2.78M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.32M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$2.02M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
-$10.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$5.2M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$4.39M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.23M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.44M |
CVAC Hedge Fund Activity: Q2 2023 in Review
88 of the 6,381 institutional investors tracked by Wall St. Rank reported a position in CureVac (CVAC) for Q2 2023, worth a combined $373M — up 46% from $256M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new CVAC positions and 12 closed out — a net gain of 7 holders — while 33 added to existing stakes and 24 trimmed.
The largest buyer was Avidity Partners Management, adding an estimated $6.71M. The largest seller was Norges Bank, cutting an estimated $10.7M.
- 88 institutional investors held CureVac (CVAC) as of Q2 2023, up from 82 in Q1 2023.
- Funds reported $373M of CureVac stock for Q2 2023, up 46% quarter-over-quarter.
- 19 funds opened new CureVac positions in Q2 2023 and 12 closed out, a net change of +7 holders.
- The largest CureVac buyer in Q2 2023 was Avidity Partners Management, an estimated $6.71M added.
- The largest CureVac seller in Q2 2023 was Norges Bank, an estimated $10.7M sold.
Based on aggregated 13F filings for Q2 2023.